| Mepolizumab for prednisone-dependent asthma with sputum eosinophilia P Nair, MMM Pizzichini, M Kjarsgaard, MD Inman, A Efthimiadis, ... New England Journal of Medicine 360 (10), 985-993, 2009 | 1635 | 2009 |
| Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised … JM FitzGerald, ER Bleecker, P Nair, S Korn, K Ohta, M Lommatzsch, ... The Lancet 388 (10056), 2128-2141, 2016 | 1378 | 2016 |
| Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma KF Rabe, P Nair, G Brusselle, JF Maspero, M Castro, L Sher, H Zhu, ... New England journal of medicine 378 (26), 2475-2485, 2018 | 1064 | 2018 |
| Oral glucocorticoid–sparing effect of benralizumab in severe asthma P Nair, S Wenzel, KF Rabe, A Bourdin, NL Lugogo, P Kuna, P Barker, ... New England journal of medicine 376 (25), 2448-2458, 2017 | 1004 | 2017 |
| Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study M Castro, S Mathur, F Hargreave, LP Boulet, F Xie, J Young, HJ Wilkins, ... American journal of respiratory and critical care medicine 184 (10), 1125-1132, 2011 | 887 | 2011 |
| Omalizumab for asthma in adults and children R Normansell, S Walker, SJ Milan, EH Walters, P Nair Cochrane database of systematic reviews, 2014 | 807 | 2014 |
| Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations L Jayaram, MM Pizzichini, RJ Cook, LP Boulet, C Lemiere, E Pizzichini, ... European Respiratory Journal 27 (3), 483-494, 2006 | 747 | 2006 |
| Altered respiratory physiology in obesity K Parameswaran, DC Todd, M Soth Canadian respiratory journal 13 (4), 203-210, 2006 | 697 | 2006 |
| Induced sputum cell counts in healthy adults J Belda, R Leigh, K Parameswaran, PM O'BYRNE, MR Sears, ... American journal of respiratory and critical care medicine 161 (2), 475-478, 2000 | 532 | 2000 |
| Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis E Pizzichini, MMM Pizzichini, P Gibson, K Parameswaran, GJ Gleich, ... American journal of respiratory and critical care medicine 158 (5), 1511-1517, 1998 | 509 | 1998 |
| Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia SG Smith, R Chen, M Kjarsgaard, C Huang, JP Oliveria, PM O'Byrne, ... Journal of Allergy and Clinical Immunology 137 (1), 75-86. e8, 2016 | 507 | 2016 |
| Role of biologics in asthma MC McGregor, JG Krings, P Nair, M Castro American journal of respiratory and critical care medicine 199 (4), 433-445, 2019 | 429 | 2019 |
| Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications D Robinson, M Humbert, R Buhl, AA Cruz, H Inoue, S Korom, NA Hanania, ... Clinical & Experimental Allergy 47 (2), 161-175, 2017 | 429 | 2017 |
| Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis AM Wilson, PM O'Byrne, K Parameswaran The American journal of medicine 116 (5), 338-344, 2004 | 380 | 2004 |
| Safety and efficacy of a CXCR 2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial P Nair, M Gaga, E Zervas, K Alagha, FE Hargreave, PM O'byrne, ... Clinical & Experimental Allergy 42 (7), 1097-1103, 2012 | 365 | 2012 |
| Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the … I Agache, J Beltran, C Akdis, M Akdis, C Canelo‐Aybar, GW Canonica, ... Allergy 75 (5), 1023-1042, 2020 | 334 | 2020 |
| Addition of intravenous aminophylline to inhaled beta2‐agonists in adults with acute asthma P Nair, SJ Milan, BH Rowe Cochrane Database of Systematic Reviews, 2012 | 334 | 2012 |
| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The Lancet Respiratory Medicine 7 (1), 46-59, 2019 | 291 | 2019 |
| EAACI Biologicals Guidelines—Recommendations for severe asthma I Agache, CA Akdis, M Akdis, GW Canonica, T Casale, T Chivato, ... Allergy 76 (1), 14-44, 2021 | 253 | 2021 |
| The trials and tribulations of IL-5, eosinophils, and allergic asthma PM O'Byrne, MD Inman, K Parameswaran Journal of allergy and clinical immunology 108 (4), 503-508, 2001 | 253 | 2001 |
